To ask the secretary of state for Health and Social Care, what recent assessment he has made of the adequacy of supply of HRT drugs.
Answered on
29 May 2020
We are aware of ongoing supply issues with some hormone replacement therapy (HRT) preparations for a variety of reasons.
The National Health Service receives regular updates on the supply situation and availability of HRT products, and we are continuing to engage with organisations such as the Royal College of Obstetricians and Gynaecologists, the Faculty of Sexual and Reproductive Healthcare and the British Menopausal Society.
We have been working closely with all suppliers to resolve the issues as quickly as possible and maintain overall supply to patients. Although some HRT products are still affected by supply issues, alternatives remain available, and the overall supply situation has been improving since February 2020 and will continue to improve over the coming months.